ADR Biomedical Holdings (TSE:3750) SpecialCharges

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3750 ADR Biomedical Holdings Inc TSE:3750
31 GF Score
Price 円779.00
GF Value 円39.88
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is ADR Biomedical Holdings SpecialCharges?

Special Charges only applies to banks.

TSE:3750
31GF Score
ADR Biomedical Holdings Inc TSE:3750
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ADR Biomedical Holdings (TSE:3750) Overvalued in 2026?

Based on GuruFocus' analysis, ADR Biomedical Holdings stock appears to be overvalued. The current stock price of 円779.00 is trading 1853.4% above its estimated GF Value™ of 円39.88. GuruFocus considers ADR Biomedical Holdings to be Significantly Overvalued.

Key valuation signals for TSE:3750:

  • SpecialCharges:
  • GF Value™: 円39.88 vs. price of 円779.00 (1853.4% above fair value)
  • GF Score™: 31/100 with 9 warning signs

No single metric tells the full story. See the TSE:3750 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ADR Biomedical Holdings Business Description

Address 1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004
ADR120S Inc developing a new clinical approach to cell therapy to provide medical care to patients by providing medical care that responds to unmet medical needs based on its regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.
31GF Score

Get the complete analysis for TSE:3750

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円779.00
Price
円39.88
GF Value